Earnings Call · Q1 FY2022·2022-05-17

Q1 22EPS -5.88%·Rev n/aQ4 21EPS -17.65%·Rev n/aQ3 21EPS -28.57%·Rev n/aQ2 21EPS +42.11%·Rev n/a⚠ consensus missing

Inhibikase Therapeutics, Inc. IKT

Alex Lobo — Host/Moderator

Milton Werner — Chief Executive Officer

Joseph Frattaroli — Chief Financial Officer

End of Q&A

+1.6%1d on move date−0.5% vs SPY3d−9.9%5d+8.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IKT calls or request research access.

More IKT calls Browse calls Request research access